NIH Funding · FY2024
Total Funding
$8.3M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#466
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $8.3M across 2 grants · National rank #466.
Top grants by award amount
John Alam's NIH grant portfolio, ranked by award amount.
- 5R01AG080536-02R01A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)$8.1Maward amount
- 3R01AG080536-02S1R01A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB)$250Kaward amount
Affiliation
Institutions that have administered grants for John Alam.
Affiliated with Eip Pharma, Inc. (MA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardEip Pharma, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #466
- 2024Entered Top 25% NationallyRanked #466
- 2024Entered Top 10% NationallyRanked #466
- 2024Entered Top 5% NationallyRanked #466
Related investigators
Other NIH-funded PIs frequently associated with John Alam.
Explore further
Find collaborators for John Alam
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Eip Pharma, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →